✦ LIBER ✦

Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood

✍ Scribed by Julie M. Fleitz; Sandra L. Wootton-Gorges; Josephine Wyatt-Ashmead; Loris McGavran; Martin Koyle; Daniel C. West; Eric A. Kurzrock; Kenneth W. Martin; Lorrie F. Odom

Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 276 KB
Volume: 33
Category: Article
ISSN: 0301-0449
DOI: 10.1007/s00247-003-0913-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes of peripheral blood lymphocyte s

Changes of peripheral blood lymphocyte subsets in a long-term survivor with advanced renal cell carcinoma

✍ Koji Yoshimura; Tamio Yamauchi; Hiroshi Maeda; Tsuneo Kawai 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 292 KB

Morbidity in long-term survivors of smal

Morbidity in long-term survivors of small cell carcinoma of the lung

✍ Stephen A. Volk; Richard F. Mansour; David R. Gandara; John Redmond III 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB 👁 2 views

Long-term follow up of renal function an

Long-term follow up of renal function and histology after renal allograft transplantation in early childhood

✍ E. Qvist; L. Krogerus; J. Laine; H. Jalanko; K. Rönnholm; K. Salmela; H. Sairane 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 175 KB

Long-term immunotherapy with low-dose in

Long-term immunotherapy with low-dose interleukin-2 and interferon-α in the treatment of patients with advanced renal cell carcinoma

✍ Carlo Buzio; Simeone Andrulli; Rosaria Santi; Laura Pavone; Rodolfo Passalacqua; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Thirteen-year, long-term efficacy of int

Thirteen-year, long-term efficacy of interferon 2α and interleukin 2-based home therapy in patients with advanced renal cell carcinoma

✍ Jens Atzpodien; Reinhard Hoffmann; Marcus Franzke; Christian Stief; Thomas Wande 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Background: The goal of the current report was to demonstrate the long-term efficacy of outpatient subcutaneous (sc) interferon alpha (ifn-alpha) and sc interleukin 2 (il-2)-based combination regimens in patients with metastatic renal cell carcinoma. ## Methods: In three consecutive clinical t

S-phase fraction as an independent progn

S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma

✍ Vielh, Philippe ;Carton, Mathieu ;Padoy, Eliane ;de Rycke, Yann ;Klijanienko, Je 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views